Results 121 to 130 of about 12,622 (181)

Management of Lower Extremity Deformity in Children with Hereditary Multiple Exostoses. [PDF]

J Pediatr Soc North Am
Whalen MJ, van Bosse HJP.
europepmc   +1 more source

De Novo Exostosin-Associated Membranous Nephropathy in Kidney Transplant. [PDF]

Kidney Int Rep
Lafaut EP, Fragoso P, Haas M, Sethi S.
europepmc   +1 more source

Identification and validation of glycosylation-related gene signatures for prognostic stratification in sepsis. [PDF]

Front Immunol
Li C, Xue H, Chen L, Zhu F, Li J.
europepmc   +1 more source

Neuropsychological tests and machine learning: identifying predictors of MCI and dementia progression. [PDF]

Aging Clin Exp Res
Cazzolli C, Chierici M, Dallabona M, Guella C, Jurman G.   +4 more
europepmc   +1 more source

Mutations in the EXT1 and EXT2 genes in patients with multiple osteochondromas from Spain

Bone, 2011
Sarrion, P, ANA SANGORRIN IRANZO, Urreizti R, Artuch-Iriberri R, Martorell-Sampol L, Armstrong-Moron J, Anton-Lopez J, Torner-Rubies F, Vilaseca MA, Balcells S, Grinberg-Vaisman DR   +10 more
openaire   +3 more sources

Membranous Nephropathy Target Antigens Display Podocyte-Specific and Non-Specific Expression in Healthy Kidneys. [PDF]

Genes (Basel)
Dong Y, Xu H, Tang D.
europepmc   +1 more source

The importance of identifying new and putative target antigens associated with membranous nephropathy: evidence from a Sardinian cohort. [PDF]

Clin Kidney J
Lepori N, Angioi A, Madden B, Floris M, Cabiddu G, Piras D, Bianco P, Mascia R, Onnis D, Fervenza FC, Sethi S, Pani A.   +11 more
europepmc   +1 more source

Windows et Ext2/ext3

Cléo Radar, 2008
openaire   +1 more source

The spectrum and prognosis of Sjögren's syndrome with membranous nephropathy. [PDF]

Clin Kidney J
Qiu DD, Li Z, Wang JJ, Chen DQ, Tu YM, Liang SS, Xu F, Liang DD, Zhang T, Cheng Z.   +9 more
europepmc   +1 more source

Palovarotene for patients with multiple hereditary exostosis: results of MO-Ped, a terminated, randomized, placebo-controlled, double-blind phase 2 trial. [PDF]

Sci Rep
Sangiorgi L, Conrad EU, Shih F, Strahs A, Feldman DS.   +4 more
europepmc   +1 more source